Skip to main content
Premium Trial:

Request an Annual Quote

Jeffrey Bluestone, Vijay Kuchroo, Christoph Lengauer, Aviv Regev, Ramnik Xavier, Alexis Borisy, Jeff Ross, Anthony Philippakis, Maya Said, Jason Coloma, Susan O'Connor

Celsius Therapeutics has named its founders and leadership team.

The company's founders are Jeffrey Bluestone, president and CEO of the Parker Institute for Cancer Immunotherapy at the University of California, San Francisco; Vijay Kuchroo, professor of neurology at Harvard Medical School; Christoph Lengauer, venture partner at Third Rock Ventures; Aviv Regev, chair of the faculty, core member, and director of the Klarman Cell Observatory at the Broad Institute; and Ramnik Xavier, chief of gastroenterology at Massachusetts General Hospital. Lengauer is also Celsius' president.

Alexis Borisy, a partner at Third Rock Ventures, serves as executive chairman of the company's board of directors, and Lengauer is a board member. Regev is a board observer, along with Jeff Ross, cofounder of Syfr, and Anthony Philippakis, a venture partner at GV (formerly Google Ventures).

The firm's management team includes Maya Said, chief operating officer; Jason Coloma, chief business officer; and Susan O'Connor, chief people officer.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.